International Pharmaceutical Excipients' Council Of India Profile
Key Indicators
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 20.82%
(FY 2022)
- Profit -145.64%
(FY 2022)
- Ebitda -126.53%
(FY 2022)
- Net Worth -0.57%
(FY 2022)
- Total Assets 1.80%
(FY 2022)
About International Pharmaceutical Excipients' Council Of India
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
Ajit Singh and Rajesh Parab serve as directors at the Company.
- CIN/LLPIN
U93000MH2014NPL252649
- Company No.
252649
- Company Classification
Private Not For Profit Company
- Incorporation Date
30 Jan 2014
- Date of AGM
18 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at International Pharmaceutical Excipients' Council Of India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Singh  | Director | 30-Jan-2014 | Current |
Rajesh Parab  | Director | 17-Mar-2023 | Current |
Financial Performance of International Pharmaceutical Excipients' Council Of India.
International Pharmaceutical Excipients' Council Of India, for the financial year ended 2022, experienced significant growth in revenue, with a 20.82% increase. The company also saw a substantial fall in profitability, with a 145.64% decrease in profit. The company's net worth dipped by a decrease of 0.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of International Pharmaceutical Excipients' Council Of India?
Unlock access to International Pharmaceutical Excipients' Council Of India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at International Pharmaceutical Excipients' Council Of India?
Unlock and access historical data on people associated with International Pharmaceutical Excipients' Council Of India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of International Pharmaceutical Excipients' Council Of India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped International Pharmaceutical Excipients' Council Of India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
